PDC*line Pharma | Biotech Hunter

About

Novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line pre-loaded with peptides

Areas of Focus

Categories

Stem Cell & Cellular Therapy

Clinical Trials (1)

View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

73

By Phase

PHASE1/PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

NCT03970746

Hover over trial bars to see details

Recent Trials

NCT03970746Lead Sponsor

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

PHASE1/PHASE2Active, not recruiting

73 participants

Started: Sep 10, 2019 · Completed: Dec 31, 2025